News
ATROVENT HFA prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and ATROVENT HFAside effects.
Further, doses of PT001 were identified that were non-inferior to Atrovent HFA. PT001 was well tolerated and no safety concerns were identified.
GlaxoSmithKline, in conjunction with Prasco, said the company launched an authorized generic for Flovent HFA in May 2022 and an authorized generic for Flovent Diskus in October 2023.
The covered products include Atrovent HFA, Combivent Respimat, Spiriva HandiHaler, Spiriva Respimat (1.25 mcg and 2.5 mcg), Stiolto Respimat, and Striverdi Respimat. 1 “Patients have counted on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results